BPMC - Blueprint Medicines Corp - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

BPMC is currently covered by 10 analysts with an average price target of $149.56. This is a potential upside of $20.1 (15.53%) from yesterday's end of day stock price of $129.46.

Blueprint Medicines Corp's activity chart (see below) currently has 383 price targets and 239 ratings on display. The stock rating distribution of BPMC is 50% BUY and 50% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 84.04% with an average time for these price targets to be met of 268.12 days.

Highest price target for BPMC is $135, Lowest price target is $129, average price target is $130.

Most recent stock forecast was given by DEREK ARCHILA from WELLS FARGO on 17-Jun-2025. First documented stock forecast 26-May-2015.

Currently out of the existing stock ratings of BPMC, 9 are a BUY (50%), 9 are a HOLD (50%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 17-Jun-2025

$129

$-0.46 (-0.36%)

$151

7 months 30 days ago
(17-Jun-2025)

10/11 (90.91%)

$0.77 (0.60%)

110

Hold Since 20-Mar-2025

$129

$-0.46 (-0.36%)

$102

8 months 11 days ago
(05-Jun-2025)

3/3 (100%)

$1.1 (0.86%)

27

Hold Since 04-Jun-2025

$129

$-0.46 (-0.36%)

$76

8 months 12 days ago
(04-Jun-2025)

11/13 (84.62%)

$0.9 (0.70%)

229

Hold Since 03-Jun-2025

$125

8 months 13 days ago
(03-Jun-2025)

16/18 (88.89%)

$35.25 (39.28%)

292

Hold Since 02-Jun-2025

$129

$-0.46 (-0.36%)

$130

8 months 14 days ago
(02-Jun-2025)

3/4 (75%)

$1.21 (0.95%)

132

Show more analysts

Please expand the browser size to see the chart

What is BPMC (Blueprint Medicines Corp) average time for price targets to be met?

On average it took 268.12 days on average for the stock forecasts to be realized with a an average price target met ratio 84.04

Which analyst has the current highest performing score on BPMC (Blueprint Medicines Corp) with a proven track record?

RENI BENJAMIN

Which analyst has the most public recommendations on BPMC (Blueprint Medicines Corp)?

Reni Benjamin works at JMP and has 1 price targets and 4 ratings on BPMC

Which analyst is the currently most bullish on BPMC (Blueprint Medicines Corp)?

Salveen Richter with highest potential upside - $38.54

Which analyst is the currently most reserved on BPMC (Blueprint Medicines Corp)?

Liana Moussatos with lowest potential downside - -$54.46

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?